,AGPCRs

Davide Provasi1, Marta Filizola1

  • 1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.

Biochemistry
|March 8, 2025
PubMed
概括

预测更安全的G蛋白结合受体 (GPCR) 药物是一个挑战. 这项研究开发了使用转移学习的AI模型来识别低效或偏差的激动剂,帮助药物发现以提高安全性.